These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25982830)

  • 1. Leadership and Licensure for Drug Treatment and the Implementation of Co-Occurring Disorder Treatment in Community Mental Health Centers.
    Guerrero EG; Padwa H; Lengnick-Hall R; Kong Y; Perrigo JL
    Community Ment Health J; 2015 Jul; 51(5):554-66. PubMed ID: 25982830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based treatment and supervision practices for co-occurring mental and substance use disorders in the criminal justice system.
    Peters RH; Young MS; Rojas EC; Gorey CM
    Am J Drug Alcohol Abuse; 2017 Jul; 43(4):475-488. PubMed ID: 28375656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assertive community treatment: facilitators and barriers to implementation in routine mental health settings.
    Mancini AD; Moser LL; Whitley R; McHugo GJ; Bond GR; Finnerty MT; Burns BJ
    Psychiatr Serv; 2009 Feb; 60(2):189-95. PubMed ID: 19176412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing program capability to provide treatment for co-occurring substance use and mental disorders: organizational characteristics.
    Gotham HJ; Claus RE; Selig K; Homer AL
    J Subst Abuse Treat; 2010 Mar; 38(2):160-9. PubMed ID: 19717273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying and ranking implicit leadership strategies to promote evidence-based practice implementation in addiction health services.
    Guerrero EG; Padwa H; Fenwick K; Harris LM; Aarons GA
    Implement Sci; 2016 May; 11():69. PubMed ID: 27180231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the capability to provide integrated mental health and substance abuse services in a state system of outpatient care.
    Sacks S; Chaple M; Sirikantraporn J; Sacks JY; Knickman J; Martinez J
    J Subst Abuse Treat; 2013; 44(5):488-93. PubMed ID: 23317513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Training substance abuse treatment staff to care for co-occurring disorders.
    Hunter SB; Watkins KE; Wenzel S; Gilmore J; Sheehe J; Griffin B
    J Subst Abuse Treat; 2005 Apr; 28(3):239-45. PubMed ID: 15857724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drivers of continued implementation of cultural competence in substance use disorder treatment.
    Guerrero EG; Khachikian T; Frimpong JA; Kong Y; Howard DL; Hunter S
    J Subst Abuse Treat; 2019 Oct; 105():5-11. PubMed ID: 31443891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing the illness management and recovery program in community mental health settings: facilitators and barriers.
    Whitley R; Gingerich S; Lutz WJ; Mueser KT
    Psychiatr Serv; 2009 Feb; 60(2):202-9. PubMed ID: 19176414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; Morse SA; MacMaster S
    Subst Use Misuse; 2015 Apr; 50(5):653-63. PubMed ID: 25587672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-based co-occurring disorder (COD) intermediate and advanced treatment for offenders.
    Melnick G; Coen C; Taxman FS; Sacks S; Zinsser KM
    Behav Sci Law; 2008; 26(4):457-73. PubMed ID: 18683204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A national survey of care for persons with co-occurring mental and substance use disorders.
    Watkins KE; Burnam A; Kung FY; Paddock S
    Psychiatr Serv; 2001 Aug; 52(8):1062-8. PubMed ID: 11474052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual diagnosis subtypes in urban substance abuse and mental health clinics.
    Hien D; Zimberg S; Weisman S; First M; Ackerman S
    Psychiatr Serv; 1997 Aug; 48(8):1058-63. PubMed ID: 9255839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-occurring disorders: policy and practice in Germany.
    Hintz T; Mann K
    Am J Addict; 2006; 15(4):261-7. PubMed ID: 16867920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescents with co-occurring mental health and substance use disorders in primary care.
    Gee RL; Espiritu RC; Huang LN
    Adolesc Med Clin; 2006 Jun; 17(2):427-52. PubMed ID: 16814701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional study of recovery training and staff attitudes in four community mental health centers.
    Tsai J; Salyers MP; McGuire AB
    Psychiatr Rehabil J; 2011; 34(3):186-93. PubMed ID: 21208857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual diagnosis demonstration project: treatment outcomes and cost analysis.
    Judd PH; Thomas N; Schwartz T; Outcalt A; Hough R
    J Psychoactive Drugs; 2003 May; 35 Suppl 1():181-92. PubMed ID: 12825761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severely and persistently mentally ill substance abusers: clinical and policy issues.
    Zweben JE
    J Psychoactive Drugs; 2000; 32(4):383-9. PubMed ID: 11210200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community context and healthcare quality: the impact of community resources on licensing and accreditation of substance abuse treatment agencies.
    Archibald ME; Rankin CP
    J Behav Health Serv Res; 2013 Oct; 40(4):442-56. PubMed ID: 23666273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights from a national survey into why substance abuse treatment units add prevention and outreach services.
    Wells R; Lemak CH; D'Aunno TA
    Subst Abuse Treat Prev Policy; 2006 Aug; 1():21. PubMed ID: 16887037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.